FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

40115011000001108: Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2052921000001118 Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2052941000001111 Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) Has dispensed dose form Prolonged-release dispersion for injection true Inferred relationship Existential restriction modifier
Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) Is a Bupivacaine liposomal 266mg/20ml prolonged-release dispersion for injection vials true Inferred relationship Existential restriction modifier
Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) Is a Exparel true Inferred relationship Existential restriction modifier
Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) Has dispensed dose form Prolonged-release dispersion for injection false Inferred relationship Existential restriction modifier
Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) Has specific active ingredient Bupivacaine liposomal true Inferred relationship Existential restriction modifier
Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) 10 vial Has AMP True Exparel liposomal 266mg/20ml prolonged-release dispersion for injection vials (Pacira Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start